Ticker brief
ENHA ENHANCED GROUP INC
Consumer, Non-cyclical · Cosmetics/Personal Care
last close
$2.56
1 day
-6.6%
14 days
-42.2%
mkt cap
·
signals 14d
12
authors 14d
5
Sentiment — last 14 days
daily mean sentiment, 2026-06-20 → 2026-07-03 · now +0.45 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @MacGillivrayCPA | C | +1.23 | 7 | +0.38 |
| @JJrit1816 | C | +0.85 | 2 | +0.35 |
| @Analytica_X | B | -1.08 | 1 | -0.40 |
| @KeithTradeSmith | C | -0.13 | 1 | +0.45 |
| @Kajiastic | C | +1.46 | 1 | +0.05 |
Recent signals12of 12 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-03 | @MacGillivrayCPA | +0.45 | Peptide market TAM and FDA compounding discussion framed as share opportunity for HIMS and ENHA. | — | tweet ↗ |
| 2026-07-02 | @MacGillivrayCPA | +0.15 | Author will attend July 23 FDA meeting on recategorization of peptides; relevant peptide-exposed tickers listed. | — | tweet ↗ |
| 2026-07-02 | @MacGillivrayCPA | +0.50 | Positive expectation for Enhanced Games event and ENHA protocol visibility. | — | tweet ↗ |
| 2026-07-02 | @Kajiastic | +0.05 | Says CCXI and ENHA are on radar but require more deep dive. | — | tweet ↗ |
| 2026-07-01 | @MacGillivrayCPA | +0.45 | FDA PCAC July 23-24 vote could move peptides from banned to permitted compounding, benefiting ENHA and HIMS. | -6.6% | tweet ↗ |
| 2026-06-30 | @KeithTradeSmith | +0.45 | Frames peptide boom as multi-year bull market with listed plays and July regulatory catalyst. | -10.8% | tweet ↗ |
| 2026-06-29 | @MacGillivrayCPA | +0.35 | FDA will assess peptide recategorization on July 23; author frames as important for ENHA. | -8.9% | tweet ↗ |
| 2026-06-27 | @JJrit1816 | +0.15 | Long HIMS peptide market thesis: regulatory thaw, media attention, PCAC/PEPMED dates, possible upside. | -9.9% | tweet ↗ |
| 2026-06-26 | @Analytica_X | -0.40 | Reports ELME -32%, HTT -24%, ENHA -17% with rate, tender and momentum pressure. | -9.9% | tweet ↗ |
| 2026-06-23 | @JJrit1816 | +0.55 | Long peptide-market thesis on ENHA as a small-cap beneficiary, with HIMS context. | -34.7% | tweet ↗ |
| 2026-06-21 | @MacGillivrayCPA | +0.20 | References a dated peptide recategorizing catalyst for ENHA without explicit trade mechanics. | -42.2% | tweet ↗ |
| 2026-06-20 | @MacGillivrayCPA | +0.55 | Says administration actions have been and will be bullish for telehealth. | -42.2% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.